Evaluation of the relationship between ACE2 G8790A and AT2R A1675G gene polymorphisms in COVID-19 patients with and without lung involvement

[1] Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000; 275:33238–43. TipnisSR HooperNM HydeR KarranE ChristieG TurnerAJ A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase J Biol Chem 2000 275 33238 43 Search in Google Scholar

[2] Devaux CA, Rolain JM, Raoult D. ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect. 2020; 53:425–35. DevauxCA RolainJM RaoultD ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome J Microbiol Immunol Infect 2020 53 425 35 Search in Google Scholar

[3] Keidar S, Kaplan M, Gamliel-Lazarovich A. ACE2 of the heart: from angiotensin I to angiotensin (1–7). Cardiovasc Res. 2007; 73:463–9. KeidarS KaplanM Gamliel-LazarovichA ACE2 of the heart: from angiotensin I to angiotensin (1–7) Cardiovasc Res 2007 73 463 9 Search in Google Scholar

[4] Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ Res. 2000; 87:E1–9. DonoghueM HsiehF BaronasE GodboutK GosselinM StaglianoN A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9 Circ Res 2000 87 E1 9 Search in Google Scholar

[5] Chamsi-Pasha MA, Shao Z, Tang WH. Angiotensin-converting enzyme 2 as a therapeutic target for heart failure. Curr Heart Fail Rep. 2014; 11:58–63. Chamsi-PashaMA ShaoZ TangWH Angiotensin-converting enzyme 2 as a therapeutic target for heart failure Curr Heart Fail Rep 2014 11 58 63 Search in Google Scholar

[6] Wiese O, Zemlin AE, Pillay TS. Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2). J Clin Pathol. 2021; 74:285–90. WieseO ZemlinAE PillayTS Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2) J Clin Pathol 2021 74 285 90 Search in Google Scholar

[7] Lemarié CA, Schiffrin EL. The angiotensin II type 2 receptor in cardiovascular disease. J Renin Angiotensin Aldosterone Syst. 2010; 11:19–31. LemariéCA SchiffrinEL The angiotensin II type 2 receptor in cardiovascular disease J Renin Angiotensin Aldosterone Syst 2010 11 19 31 Search in Google Scholar

[8] Fatima N, Patel SN, Hussain T. Angiotensin II type 2 receptor: a target for protection against hypertension, metabolic dysfunction, and organ remodeling. Hypertension. 2021; 77:1845–56. FatimaN PatelSN HussainT Angiotensin II type 2 receptor: a target for protection against hypertension, metabolic dysfunction, and organ remodeling Hypertension 2021 77 1845 56 Search in Google Scholar

[9] Lazard D, Briend-Sutren MM, Villageois P, Mattei MG, Strosberg AD, Nahmias C. Molecular characterization and chromosome localization of a human angiotensin II AT2 receptor gene highly expressed in fetal tissues. Recept Channels. 1994; 2:271–80. LazardD Briend-SutrenMM VillageoisP MatteiMG StrosbergAD NahmiasC Molecular characterization and chromosome localization of a human angiotensin II AT2 receptor gene highly expressed in fetal tissues Recept Channels 1994 2 271 80 Search in Google Scholar

[10] Inagami T. Molecular biology and signaling of angiotensin receptors: an overview. J Am Soc Nephrol. 1999; 10(Suppl 11):S2–7. InagamiT Molecular biology and signaling of angiotensin receptors: an overview J Am Soc Nephrol 1999 10 Suppl 11 S2 7 Search in Google Scholar

[11] Martin MM, Elton TS. The sequence and genomic organization of the human type 2 angiotensin II receptor. Biochem Biophys Res Commun. 1995; 209:554–62. MartinMM EltonTS The sequence and genomic organization of the human type 2 angiotensin II receptor Biochem Biophys Res Commun 1995 209 554 62 Search in Google Scholar

[12] Felsenstein S, Herbert JA, McNamara PS, Hedrich CM. COVID-19: immunology and treatment options. Clin Immunol. 2020; 215:108448. doi: 10.1016/j.clim.2020.108448 FelsensteinS HerbertJA McNamaraPS HedrichCM COVID-19: immunology and treatment options Clin Immunol 2020 215 108448 10.1016/j.clim.2020.108448 Open DOISearch in Google Scholar

[13] Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020; 24:422. doi: 10.1186/s13054-020-03120-0 NiW YangX YangD BaoJ LiR XiaoY Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 Crit Care 2020 24 422 10.1186/s13054-020-03120-0 Open DOISearch in Google Scholar

[14] Huertas A, Montani D, Savale L, Pichon J, Tu L, Parent F, et al. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J. 2020; 56:2001634. doi: 10.1183/13993003.01634-2020 HuertasA MontaniD SavaleL PichonJ TuL ParentF Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J 2020 56 2001634 10.1183/13993003.01634-2020 Open DOISearch in Google Scholar

[15] Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005; 11:875–9. KubaK ImaiY RaoS GaoH GuoF GuanB A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury Nat Med 2005 11 875 9 Search in Google Scholar

[16] Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Hum Genet. 2009; 125:131–51. LittleJ HigginsJP IoannidisJP MoherD GagnonF von ElmE Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement Hum Genet 2009 125 131 51 Search in Google Scholar

[17] World Health Organization. Living guidance clinical management of COVID-19. [Internet]. 2023. [cited 2023 January 15]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2 World Health Organization Living guidance clinical management of COVID-19 [Internet]. 2023. [cited 2023 January 15]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2 Search in Google Scholar

[18] Fistera D, Risse J, Manegold R, Pabst D, Konik M, Dolff S, et al. [COVID-19 triage: who is an inpatient? the Essen triage model]. Dtsch Med Wochenschr. 2020; 145:e87–92. FisteraD RisseJ ManegoldR PabstD KonikM DolffS [COVID-19 triage: who is an inpatient? the Essen triage model] Dtsch Med Wochenschr 2020 145 e87 92 Search in Google Scholar

[19] Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. Radiological society of North America expert consensus document on reporting chest CT findings related to COVID-19: endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiol Cardiothorac Imaging. 2020; 2:e200152. doi: 10.1148/ryct.2020200152 SimpsonS KayFU AbbaraS BhallaS ChungJH ChungM Radiological society of North America expert consensus document on reporting chest CT findings related to COVID-19: endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA Radiol Cardiothorac Imaging 2020 2 e200152 10.1148/ryct.2020200152 Open DOISearch in Google Scholar

[20] Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology. 2020; 295:200463. doi: 10.1148/radiol.2020200463 BernheimA MeiX HuangM YangY FayadZA ZhangN Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection Radiology 2020 295 200463 10.1148/radiol.2020200463 Open DOISearch in Google Scholar

[21] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395:1054–62. ZhouF YuT DuR FanG LiuY LiuZ Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 2020 395 1054 62 Search in Google Scholar

[22] Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020; 180:934–43. WuC ChenX CaiY XiaJ ZhouX XuS Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China JAMA Intern Med 2020 180 934 43 Search in Google Scholar

[23] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395:497–506. HuangC WangY LiX RenL ZhaoJ HuY Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 2020 395 497 506 Search in Google Scholar

[24] Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18:844–7. TangN LiD WangX SunZ Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia J Thromb Haemost 2020 18 844 7 Search in Google Scholar

[25] Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020; 18:1421–4. CuiS ChenS LiX LiuS WangF Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia J Thromb Haemost 2020 18 1421 4 Search in Google Scholar

[26] Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020; 18:1094–9. TangN BaiH ChenX GongJ LiD SunZ Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy J Thromb Haemost 2020 18 1094 9 Search in Google Scholar

[27] Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020; 39:1011–9. GeH WangX YuanX XiaoG WangC DengT The epidemiology and clinical information about COVID-19 Eur J Clin Microbiol Infect Dis 2020 39 1011 9 Search in Google Scholar

[28] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323:1061–9. WangD HuB HuC ZhuF LiuX ZhangJ Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China JAMA 2020 323 1061 9 Search in Google Scholar

[29] Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-CoV-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368:m606. doi: 10.1136/bmj.m606 XuXW WuXX JiangXG XuKJ YingLJ MaCL Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-CoV-2) outside of Wuhan, China: retrospective case series BMJ 2020 368 m606 10.1136/bmj.m606 Open DOISearch in Google Scholar

[30] Kocak FE, Akcilar R, Kar F, Isiklar OO, Atlanoglu S, Genc O, Yaman F. The D allele of angiotensin-converting enzyme gene insertion/deletion polymorphism is associated with the lung involvement in COVID-19. Turkish J Biochem. 2022; 48: 160–7. KocakFE AkcilarR KarF IsiklarOO AtlanogluS GencO YamanF The D allele of angiotensin-converting enzyme gene insertion/deletion polymorphism is associated with the lung involvement in COVID-19 Turkish J Biochem 2022 48 160 7 Search in Google Scholar

[31] Santos RAS, Sampaio WO, Alzamora AC, Motta-Santos D, Alenina N, Bader M, Campagnole-Santos MJ. The ACE2/angiotensin-(1–7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1–7). Physiol Rev. 2018; 98:505–53. SantosRAS SampaioWO AlzamoraAC Motta-SantosD AleninaN BaderM Campagnole-SantosMJ The ACE2/angiotensin-(1–7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1–7) Physiol Rev 2018 98 505 53 Search in Google Scholar

[32] Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005; 436:112–6. ImaiY KubaK RaoS HuanY GuoF GuanB Angiotensin-converting enzyme 2 protects from severe acute lung failure Nature 2005 436 112 6 Search in Google Scholar

[33] Sriram K, Insel PA. A hypothesis for pathobiology and treatment of COVID-19: the centrality of ACE1/ACE2 imbalance. Br J Pharmacol. 2020; 177:4825–44. SriramK InselPA A hypothesis for pathobiology and treatment of COVID-19: the centrality of ACE1/ACE2 imbalance Br J Pharmacol 2020 177 4825 44 Search in Google Scholar

[34] Kramkowski K, Mogielnicki A, Buczko W. The physiological significance of the alternative pathways of angiotensin II production. J Physiol Pharmacol. 2006; 57:529–39. KramkowskiK MogielnickiA BuczkoW The physiological significance of the alternative pathways of angiotensin II production J Physiol Pharmacol 2006 57 529 39 Search in Google Scholar

[35] Hou Y, Zhao J, Martin W, Kallianpur A, Chung MK, Jehi L, et al. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. BMC Med. 2020; 18:216. doi: 10.1186/s12916-020-01673-z HouY ZhaoJ MartinW KallianpurA ChungMK JehiL New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis BMC Med 2020 18 216 10.1186/s12916-020-01673-z Open DOISearch in Google Scholar

[36] Karakaş Çelik S, Çakmak Genç G, Pişkin N, Açikgöz B, Altinsoy B, Kurucu İşsiz B, Dursun A. Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: a case study. J Med Virol. 2021; 93:5947–52. Karakaş ÇelikS Çakmak GençG PişkinN AçikgözB AltinsoyB Kurucu İşsizB DursunA Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: a case study J Med Virol 2021 93 5947 52 Search in Google Scholar

[37] Novelli A, Biancolella M, Borgiani P, Cocciadiferro D, Colona VL, D'Apice MR, et al. Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients. Hum Genomics. 2020; 14:29. doi: 10.1186/s40246-020-00279-z NovelliA BiancolellaM BorgianiP CocciadiferroD ColonaVL D'ApiceMR Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients Hum Genomics 2020 14 29 10.1186/s40246-020-00279-z Open DOISearch in Google Scholar

[38] Malik GH, Bhat IA, Rasool S, Bashir I, Bashir A, Dar TA, et al. SARS-CoV-2-IgG response and the role of ACE2 G8790A and ACE I/D polymorphic variants as determinants of Covid-19 severity-a genetic association study in north Indian population. Research Square; 2021. doi: 10.21203/rs.3.rs-764798/v1. MalikGH BhatIA RasoolS BashirI BashirA DarTA SARS-CoV-2-IgG response and the role of ACE2 G8790A and ACE I/D polymorphic variants as determinants of Covid-19 severity-a genetic association study in north Indian population Research Square 2021 10.21203/rs.3.rs-764798/v1 Open DOISearch in Google Scholar

[39] Möhlendick B, Schönfelder K, Breuckmann K, Elsner C, Babel N, Balfanz P, et al. ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19. Pharmacogenet Genomics. 2021; 31:165–71. MöhlendickB SchönfelderK BreuckmannK ElsnerC BabelN BalfanzP ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19 Pharmacogenet Genomics 2021 31 165 71 Search in Google Scholar

[40] Srivastava A, Bandopadhyay A, Das D, Pandey RK, Singh V, Khanam N, et al. Genetic association of ACE2 rs2285666 polymorphism with COVID-19 spatial distribution in India. Front Genet. 2020; 25:564741. doi: 10.3389/fgene.2020.564741 SrivastavaA BandopadhyayA DasD PandeyRK SinghV KhanamN Genetic association of ACE2 rs2285666 polymorphism with COVID-19 spatial distribution in India Front Genet 2020 25 564741 10.3389/fgene.2020.564741 Open DOISearch in Google Scholar

[41] Asselta R, Paraboschi EM, Mantovani A, Duga S. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging (Albany NY). 2020; 12:10087–98. AsseltaR ParaboschiEM MantovaniA DugaS ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy Aging (Albany NY) 2020 12 10087 98 Search in Google Scholar

[42] Gómez J, Albaiceta GM, García-Clemente M, López-Larrea C, Amado-Rodríguez L, Lopez-Alonso I, et al. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome. Gene. 2020; 762:145102. doi: 10.1016/j.gene.2020.145102 GómezJ AlbaicetaGM García-ClementeM López-LarreaC Amado-RodríguezL Lopez-AlonsoI Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome Gene 2020 762 145102 10.1016/j.gene.2020.145102 Open DOISearch in Google Scholar

[43] Patel SK, Juno JA, Lee WS, Wragg KM, Hogarth PM, Kent SJ, Burrell LM. Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences. Eur Respir J. 2021; 57:2003730. doi: 10.1183/13993003.03730-2020 PatelSK JunoJA LeeWS WraggKM HogarthPM KentSJ BurrellLM Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences Eur Respir J 2021 57 2003730 10.1183/13993003.03730-2020 Open DOISearch in Google Scholar

[44] van Lier D, Kox M, Santos K, van der Hoeven H, Pillay J, Pickkers P. Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patients. ERJ Open Res. 2021; 7:00848–2020. van LierD KoxM SantosK van der HoevenH PillayJ PickkersP Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patients ERJ Open Res 2021 7 00848 2020 Search in Google Scholar

[45] Nagy B Jr, Fejes Z, Szentkereszty Z, Sütő R, Várkonyi I, Ajzner É, et al. A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient. Int J Infect Dis. 2021; 103:412–4. NagyBJr FejesZ SzentkeresztyZ SütőR VárkonyiI AjznerÉ A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient Int J Infect Dis 2021 103 412 4 Search in Google Scholar

[46] Kornilov SA, Lucas I, Jade K, Dai CL, Lovejoy JC, Magis AT. Plasma levels of soluble ACE2are associated with sex, Metabolic Syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19. Crit Care. 2020; 24:452. doi: 10.1186/s13054-020-03141-9 KornilovSA LucasI JadeK DaiCL LovejoyJC MagisAT Plasma levels of soluble ACE2are associated with sex, Metabolic Syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19 Crit Care 2020 24 452 10.1186/s13054-020-03141-9 Open DOISearch in Google Scholar

[47] Wu YH, Li JY, Wang C, Zhang LM, Qiao H. The ACE2 G8790A polymorphism: involvement in type 2 diabetes mellitus combined with cerebral stroke. J Clin Lab Anal. 2017; 31:e22033. doi: 10.1002/jcla.22033 WuYH LiJY WangC ZhangLM QiaoH The ACE2 G8790A polymorphism: involvement in type 2 diabetes mellitus combined with cerebral stroke J Clin Lab Anal 2017 31 e22033 10.1002/jcla.22033 Open DOISearch in Google Scholar

[48] Steckelings UM, Sumners C. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists. Clin Sci (Lond). 2020; 134:2987–3006. SteckelingsUM SumnersC Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists Clin Sci (Lond) 2020 134 2987 3006 Search in Google Scholar

[49] Gumashta J, Gumashta R. Role of the backbenchers of the renin-angiotensin system ACE2 and AT2 receptors in COVID-19: lessons from SARS. Cureus. 2020; 12:e8411. doi: 10.7759/cureus.8411 GumashtaJ GumashtaR Role of the backbenchers of the renin-angiotensin system ACE2 and AT2 receptors in COVID-19: lessons from SARS Cureus 2020 12 e8411 10.7759/cureus.8411 Open DOISearch in Google Scholar

[50] Živković M, Kolaković A, Stojković L, Dinčić E, Kostić S, Alavantić D, Stanković A. Renin-angiotensin system gene polymorphisms as risk factors for multiple sclerosis. J Neurol Sci. 2016; 15:29–32. ŽivkovićM KolakovićA StojkovićL DinčićE KostićS AlavantićD StankovićA Renin-angiotensin system gene polymorphisms as risk factors for multiple sclerosis J Neurol Sci 2016 15 29 32 Search in Google Scholar